Daniela Nachmanson

MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future

Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy

Ultra-Sensitive TP53 Sequencing for Cancer Detection Reveals Progressive Clonal Selection in Normal Tissue over a Century of Human Lifespan

Targeted genome fragmentation with CRISPR/Cas9 enables fast and efficient enrichment of small genomic regions and ultra-accurate sequencing with low DNA input (CRISPR-DS)